• Je něco špatně v tomto záznamu ?

Neural Stem Cells Derived from Human-Induced Pluripotent Stem Cells and Their Use in Models of CNS Injury

P. Jendelova, E. Sykova, S. Erceg,

. 2018 ; 66 (-) : 89-102. [pub] -

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035019

Induced pluripotent stem (iPS) cells are derived from differentiated cells by different reprogramming techniques, by introducing specific transcription factors responsible for pluripotency. Induced pluripotent stem cells can serve as an excellent source for differentiated neural stem/progenitor cells (NSCs/NPs). Several methods and protocols are utilized to create a robust number of NSCs/NPs without jeopardizing the safety issues required for in vivo applications. A variety of disease-specific iPS cells have been used to study nervous system diseases. In this chapter, we will focus on some of the derivation and differentiation approaches and the application of iPS-NPs in the treatment of spinal cord injury and stroke.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035019
003      
CZ-PrNML
005      
20191017090140.0
007      
ta
008      
191007s2018 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/978-3-319-93485-3_3 $2 doi
035    __
$a (PubMed)30209655
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Jendelova, Pavla $u Institute of Experimental Medicine ASCR, Prague, Czech Republic. pavla.jendelova@iem.cas.cz.
245    10
$a Neural Stem Cells Derived from Human-Induced Pluripotent Stem Cells and Their Use in Models of CNS Injury / $c P. Jendelova, E. Sykova, S. Erceg,
520    9_
$a Induced pluripotent stem (iPS) cells are derived from differentiated cells by different reprogramming techniques, by introducing specific transcription factors responsible for pluripotency. Induced pluripotent stem cells can serve as an excellent source for differentiated neural stem/progenitor cells (NSCs/NPs). Several methods and protocols are utilized to create a robust number of NSCs/NPs without jeopardizing the safety issues required for in vivo applications. A variety of disease-specific iPS cells have been used to study nervous system diseases. In this chapter, we will focus on some of the derivation and differentiation approaches and the application of iPS-NPs in the treatment of spinal cord injury and stroke.
650    12
$a buněčná diferenciace $7 D002454
650    _2
$a přeprogramování buněk $7 D065150
650    _2
$a lidé $7 D006801
650    _2
$a indukované pluripotentní kmenové buňky $x cytologie $7 D057026
650    12
$a modely neurologické $7 D008959
650    _2
$a nervové kmenové buňky $x cytologie $7 D058953
650    _2
$a poranění míchy $x patologie $x terapie $7 D013119
650    _2
$a cévní mozková příhoda $x patologie $x terapie $7 D020521
650    _2
$a transkripční faktory $x metabolismus $7 D014157
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sykova, Eva $u 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Erceg, Slaven $u Institute of Experimental Medicine ASCR, Prague, Czech Republic. Research Center Principe Felipe, Valencia, Spain.
773    0_
$w MED00193483 $t Results and problems in cell differentiation $x 0080-1844 $g Roč. 66, č. - (2018), s. 89-102
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30209655 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191017090608 $b ABA008
999    __
$a ok $b bmc $g 1451679 $s 1073569
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 66 $c - $d 89-102 $e - $i 0080-1844 $m Results and problems in cell differentiation $n Results Probl Cell Differ $x MED00193483
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace